All treatments Research

AAV gene therapy

Researchers can pack a working NPC1 gene into an engineered adeno-associated virus (AAV) capsid. That is gene addition — a different tool from the mRNA and prime-editing path Life 4 Liam funds.

Still image of AAV gene therapy
A still of the idea behind AAV gene therapy. The motion below is a simple animation, not a replacement for this picture.

How it works

AAV — adeno-associated virus — is used as a delivery shell, not as an infection. Scientists can load a DNA copy of working NPC1 into that capsid so cells that take it up may make the missing protein. In mice, AAV9 NPC1 gene therapy has extended lifespan and improved motor function. Expression can last because the DNA usually stays as an extra episome, not because the original mutation is corrected.

That is a different class of gene therapy from messenger RNA, which is a temporary instruction that can typically be given again, and from prime editing, which aims to correct the gene itself. AAV’s known limits include pre-existing neutralizing antibodies in some people, difficulty repeating a dose after the first, and a dose-and-immune-safety discussion that is specific to viral vectors. Those are field facts, not a judgment on teams doing AAV work. Life 4 Liam funds lipid-nanoparticle mRNA first, then prime editing.

Who it is for

Still investigational for NPC. AAV9 and related capsids have shown benefit in NPC1 mouse studies. There is no FDA-approved AAV medicine for NPC. It is not the Iowa mRNA program.

What it does not do

It does not rewrite the person’s existing NPC1 gene the way prime editing aims to. It adds an extra working copy. Antibodies to AAV (from nature or from a prior dose) can block treatment, and redosing the same capsid is often limited. High-dose AAV also has its own safety conversation with a specialist — liver, immune response, and who can receive it.

Step by step

What this treatment does

Four short pictures of the idea. Play through, or tap a step. This is a teaching picture, not a medical simulation.

Step 1 of 4 · The idea

A small viral shell can carry DNA

AAV is an engineered adeno-associated virus. Scientists can pack a working NPC1 gene into that shell.

Educational only. Ask an NPC specialist what is right for a specific child or adult. Official sites and FDA pages are the source of prescribing information.